Roadrunner Capitol Reports Roadrunner Capitol Reports
Legislation Detail
HB 152 MEDICALLY ASSISTED TREATMENT FOR JUVENILES
Sponsored By: Rep Eleanor Chavez

Actions: [2] HHHC/HAFC-HHHC [4] DP-HAFC

Scheduled: Not Scheduled

Summary:
 House Bill 152 (HB 152):  This act mandates that by the end of fiscal year 2026, facilities and programs providing substance use disorder treatment to minors in New Mexico—including inpatient and outpatient facilities, juvenile correction facilities, and juvenile detention facilities—must not have policies that restrict the use of medication-assisted treatment (MAT).  
Legislation Overview:
 House Bill 152 (HB 152):  This act recommends the following guidelines: 
a)	Prohibition of MAT Restrictions: State-operated or contracted treatment facilities cannot have policies that limit the use of MAT, which combines medication with counseling and behavioral therapies to treat substance use disorders.
b)	Medicaid Reimbursement: Facilities with restrictive MAT policies will not be eligible for Medicaid reimbursements for services provided to minors starting July 1, 2026.
c)	Rulemaking: The Health Care Authority, in collaboration with relevant departments and stakeholders, must establish rules for implementing MAT programs by December 1, 2025.
d)	Annual Reporting: The Health Care Authority must annually report to the legislative committee on the availability of MAT in the designated facilities starting from October 1, 2025.

Accessibility of Treatment: This acts recommendation ensures minors with substance use disorders have access to comprehensive treatments, including MAT, which is recognized for improving treatment outcomes.  Regulatory Oversight would establish uniform guidelines across various facilities ensures that treatment practices meet current standards and are scientifically supported.

The creation of the Evidence-Based Substance Use Disorder Treatment for Minors Fund supports the development and operation of MAT programs, indicating a commitment to sustainable treatment options.  Facilities must adjust their treatment policies to comply with new regulations, which may involve training staff, altering administrative policies, and potentially facing financial implications if they fail to comply.

Healthcare Costs: By potentially improving treatment outcomes, MAT may reduce long-term healthcare costs associated with substance use disorders.  Effective treatment during adolescence can significantly alter life trajectories, reducing future interaction with the criminal justice system and improving overall life outcomes.

This act reflects a shift towards evidence-based public health strategies in addressing substance use disorders among minors, emphasizing both treatment efficacy and accessibility.

Overall, this legislative act represents a progressive approach to treating substance use disorders in minors by promoting evidence-based treatments and ensuring that regulatory and funding mechanisms are aligned to support these initiatives effectively.
 
  • Commitee Reports & Amendments arrow_drop_down
  • Floor Amendments arrow_drop_down